Authors:
WITTCHEN HU
PERKONIGG A
LACHNER G
NELSON CB
Citation: Hu. Wittchen et al., EARLY DEVELOPMENTAL STAGES OF PSYCHOPATHOLOGY STUDY (EDSP) - OBJECTIVES AND DESIGN, European addiction research, 4(1-2), 1998, pp. 18-27
Citation: Cb. Nelson et Hu. Wittchen, SMOKING AND NICOTINE DEPENDENCE - RESULTS FROM A SAMPLE OF 14 TO 24-YEAR-OLDS IN GERMANY, European addiction research, 4(1-2), 1998, pp. 42-49
Citation: Cb. Nelson et Hu. Wittchen, DSM-IV ALCOHOL DISORDERS IN A GENERAL-POPULATION SAMPLE OF ADOLESCENTS AND YOUNG-ADULTS, Addiction, 93(7), 1998, pp. 1065-1077
Authors:
CORBIN AE
PUGSLEY TA
AKUNNE HC
WHETZEL SZ
ZOSKI KT
GEORGIC LM
NELSON CB
WRIGHT JL
WISE LD
HEFFNER TG
Citation: Ae. Corbin et al., PHARMACOLOGICAL CHARACTERIZATION OF PD-152255, A NOVEL DIMERIC BENZIMIDAZOLE DOPAMINE D-3 ANTAGONIST, Pharmacology, biochemistry and behavior, 59(2), 1998, pp. 487-493
Citation: Hu. Wittchen et al., PREVALENCE OF MENTAL-DISORDERS AND PSYCHOSOCIAL IMPAIRMENTS IN ADOLESCENTS AND YOUNG-ADULTS, Psychological medicine, 28(1), 1998, pp. 109-126
Authors:
TECLE H
BARRETT SD
LAUFFER DJ
AUGELLISZAFRAN C
BRANN MR
CALLAHAN MJ
CAPRATHE BW
DAVIS RE
DOYLE PD
EUBANKS D
LIPINISKI W
MIRZADEGAN T
MOOS WH
MORELAND DW
NELSON CB
PAVIA MR
RABY C
SCHWARZ RD
SPENCER CJ
THOMAS AJ
JAEN JC
Citation: H. Tecle et al., DESIGN AND SYNTHESIS OF M1-SELECTIVE MUSCARINIC AGONISTS - (R)-(-)-(Z)-1-AZABICYCLO[2.2.1]HEPTAN-3-ONE, O-(3-(3'-METHOXYPHENYL)-2-PROPYNYL)OXIME MALEATE (CI-1017), A FUNCTIONALLY M1-SELECTIVE MUSCARINIC AGONIST, Journal of medicinal chemistry, 41(14), 1998, pp. 2524-2536
Citation: Cb. Nelson et al., TEMPORAL PROGRESSION OF ALCOHOL DEPENDENCE SYMPTOMS IN THE US HOUSEHOLD POPULATION - RESULTS FROM THE NATIONAL COMORBIDITY SURVEY, Journal of consulting and clinical psychology, 66(3), 1998, pp. 474-483
Citation: Cb. Nelson et al., THE ICRP-PUBLICATION-60 FORMULATION OF REMAINDER DOSE AND ITS CONTRIBUTION TO EFFECTIVE DOSE IN INTERNAL DOSIMETRY, Radiation protection dosimetry, 71(1), 1997, pp. 33-40
Authors:
PERKONIGG A
BELOCH E
GARZYNSKI E
NELSON CB
PFISTER H
WITTCHEN HU
Citation: A. Perkonigg et al., PREVALENCE OF DRUG-ABUSE AND DEPENDENCE - USE OF ILLICIT SUBSTANCES, DIAGNOSIS AND ONSET OF FIRST ABUSE AND DEPENDENCE SYMPTOMS, Zeitschrift fur klinische Psychologie, 26(4), 1997, pp. 247-257
Authors:
HOLLY A
TURK D
NELSON CB
PFISTER H
WITTCHEN HU
Citation: A. Holly et al., PREVALENCE OF ALCOHOL-USE, ABUSE AND DEPE NDENCE IN ADOLESCENTS AND YOUNG-ADULTS, Zeitschrift fur klinische Psychologie, 26(3), 1997, pp. 171-178
Authors:
SCHWARZ RD
NELSON CB
AUGELLISZAFRAN CE
PENVOSE JR
JAEN JC
WILEY J
FREY KA
Citation: Rd. Schwarz et al., PHARMACOLOGICAL CHARACTERIZATION OF PD182807 - AN M4 SUBTYPE-SELECTIVE MUSCARINIC ANTAGONIST, Life sciences, 60(13-14), 1997, pp. 10-10
Authors:
AUGELLISZAFRAN CE
MORELAND DW
NELSON CB
PENVOSEYI JR
SCHWARZ RD
JEAN JC
Citation: Ce. Augelliszafran et al., IDENTIFICATION AND CHARACTERIZATION OF M4 SELECTIVE MUSCARINIC ANTAGONISTS, Life sciences, 60(13-14), 1997, pp. 11-11
Authors:
KESSLER RC
CRUM RM
WARNER LA
NELSON CB
SCHULENBERG J
ANTHONY JC
Citation: Rc. Kessler et al., LIFETIME COOCCURRENCE OF DSM-III-R ALCOHOL-ABUSE AND DEPENDENCE WITH OTHER PSYCHIATRIC-DISORDERS IN THE NATIONAL COMORBIDITY SURVEY, Archives of general psychiatry, 54(4), 1997, pp. 313-321
Citation: Cb. Nelson et al., PATTERNS OF DSM-III-R ALCOHOL DEPENDENCE SYMPTOM PROGRESSION IN A GENERAL-POPULATION SURVEY, Psychological medicine, 26(3), 1996, pp. 449-460
Authors:
KESSLER RC
NELSON CB
MCGONAGLE KA
LIU J
SWARTZ M
BLAZER DG
Citation: Rc. Kessler et al., COMORBIDITY OF DSM-III-R MAJOR DEPRESSIVE DISORDER IN THE GENERAL-POPULATION - RESULTS FROM THE US NATIONAL COMORBIDITY SURVEY, British Journal of Psychiatry, 168, 1996, pp. 17-30
Authors:
KESSLER RC
NELSON CB
MCGONAGLE KA
EDLUND MJ
FRANK RG
LEAF PJ
Citation: Rc. Kessler et al., THE EPIDEMIOLOGY OF COOCCURRING ADDICTIVE AND MENTAL-DISORDERS - IMPLICATIONS FOR PREVENTION AND SERVICE UTILIZATION, American journal of orthopsychiatry, 66(1), 1996, pp. 17-31
Authors:
AUGELLISZAFRAN CE
BLANKLEY CJ
JAEN JC
MORELAND DW
NELSON CB
PENVOSE JR
SCHWARZ RD
THOMAS AJ
Citation: Ce. Augelliszafran et al., IDENTIFICATION AND CHARACTERIZATION OF M1 SELECTIVE MUSCARINIC ANTAGONISTS, Life sciences, 56(11-12), 1995, pp. 1017-1017
Authors:
NELSON CB
AUGELLISZAFRAN CE
CALLAHAN MJ
CHRISTOFFERSEN C
JAEN JC
MELTZER LT
PENVOSE JR
SCHWARZ RD
THOMAS AJ
WILEY J
Citation: Cb. Nelson et al., PHARMACOLOGICAL CHARACTERIZATION OF PD150714 - AN M1 SELECTIVE MUSCARINIC ANTAGONIST, Life sciences, 56(11-12), 1995, pp. 1017-1017
Authors:
BIGGE CF
MALONE TC
BOXER PA
NELSON CB
ORTWINE DF
SCHELKUN RM
RETZ DM
LESCOSKY LJ
BOROSKY SA
VARTANIAN MG
SCHWARZ RD
CAMPBELL GW
ROBICHAUD LJ
WATJEN F
Citation: Cf. Bigge et al., SYNTHESIS OF -METHYL-6-NITROPYRIDO[3,4-F]-QUINOXALINE-2,3-DIONE AND RELATED QUINOXALINEDIONES - CHARACTERIZATION OF LPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID (AND N-METHYL-D-ASPARTATE) RECEPTOR AND ANTICONVULSANT ACTIVITY, Journal of medicinal chemistry, 38(19), 1995, pp. 3720-3740
Authors:
WARNER LA
KESSLER RC
HUGHES M
ANTHONY JC
NELSON CB
Citation: La. Warner et al., PREVALENCE AND CORRELATES OF DRUG-USE AND DEPENDENCE IN THE UNITED-STATES - RESULTS FROM THE NATIONAL COMORBIDITY SURVEY, Archives of general psychiatry, 52(3), 1995, pp. 219-229
Authors:
KESSLER RC
SONNEGA A
BROMET E
HUGHES M
NELSON CB
Citation: Rc. Kessler et al., POSTTRAUMATIC-STRESS-DISORDER IN THE NATIONAL COMORBIDITY SURVEY, Archives of general psychiatry, 52(12), 1995, pp. 1048-1060
Citation: Cb. Nelson et al., THE ASSOCIATION OF DIABETIC STATUS, AGE, AND RACE TO WITHDRAWAL FROM DIALYSIS, Journal of the American Society of Nephrology, 4(8), 1994, pp. 1608-1614